ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014 Published on June 2014
Report Summary Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, 'Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014" provides data on the Globoid Cell Leukodystrophy (Krabbe Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Globoid Cell Leukodystrophy (Krabbe Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Globoid Cell Leukodystrophy (Krabbe Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Content Table of Contents Introduction 6 Globoid Cell Leukodystrophy (Krabbe Disease) 6 Report Guidance 6 Clinical Trials by Region 7
Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014 (From Issuu)
Page 1/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Clinical Trials and Average Enrollment by Country 8 Top Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials by Phase 19 In Progress Trials by Phase 20 Clinical Trials by Trial Status 21 Clinical Trials by End Point Status 22 Unaccomplished Trials of Globoid Cell Leukodystrophy (Krabbe Disease) 23 Subjects Recruited Over a Period of Time 26 Clinical Trials by Sponsor Type 27 Prominent Sponsors 28 Top Companies Participating in Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials 29 Prominent Drugs 30 Clinical Trial Profiles 31 Clinical Trial Overview of Top Companies 31 Zymenex A/S 31 Clinical Trial Overview of Zymenex A/S 31 Shire Plc 32 Clinical Trial Overview of Shire Plc 32 Fate Therapeutics, Inc. 33 Clinical Trial Overview of Fate Therapeutics, Inc. 33 Cytomedix, Inc. 34 Clinical Trial Overview of Cytomedix, Inc. 34 Clinical Trial Overview of Top Institutes / Government 35 Masonic Cancer Center 35 Clinical Trial Overview of Masonic Cancer Center 35 University of Rostock 36 Clinical Trial Overview of University of Rostock 36 Fairview University Medical Center 37 Clinical Trial Overview of Fairview University Medical Center 37 New York Medical College 38 Clinical Trial Overview of New York Medical College 38 Center for International Blood and Marrow Transplant Research 39 Clinical Trial Overview of Center for International Blood and Marrow Transplant Research 39 University of Chicago 40 Clinical Trial Overview of University of Chicago 40 University of Louisville 41 Clinical Trial Overview of University of Louisville 41 National Center for Research Resources 42
Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014 (From Issuu)
Page 2/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Clinical Trial Overview of National Center for Research Resources 42 National Cancer Institute 43 Clinical Trial Overview of National Cancer Institute 43 University of Pittsburgh 44 Clinical Trial Overview of University of Pittsburgh 44 Five Key Clinical Profiles 45 Appendix 68 Abbreviations 68 Definitions 68 Research Methodology 69 Secondary Research 69 About GlobalData 70 Contact Us 70 Disclaimer 70 Source 70
List of Tables Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Region, 2014* 7 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13 Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16 Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Phase, 2014* 19 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Suspended Clinical Trials, 2014* 23 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Terminated Clinical Trials, 2014* 25 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zymenex A/S, 2014* 31 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014* 32 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fate Therapeutics, Inc.,
Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014 (From Issuu)
Page 3/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! 2014* 33 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytomedix, Inc., 2014* 34 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2014* 35 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rostock, 2014* 36 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fairview University Medical Center, 2014* 37 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by New York Medical College, 2014* 38 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for International Blood and Marrow Transplant Research, 2014* 39 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014* 40 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Louisville, 2014* 41 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 42 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 43 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 44
List of Figures Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16 Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29 Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30 GlobalData Methodology 69
Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014 (From Issuu)
Page 4/6
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014
Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 500.00
Quantity: _____
Site License--USD 5 000.00
Quantity: _____
Corporate License--USD 7 500.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014 (From Issuu)
Page 5/6
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014 (From Issuu)
Page 6/6